Acadian Asset Management »

Entrada Therapeutics shares owned by Acadian Asset Management

Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by Acadian Asset Management from 13F filings

Historical chart of Acadian Asset Management investment in Entrada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Entrada Therapeutics held by Acadian Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Entrada Therapeutics by Acadian Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.7M 298k 5.79
2025-06-30 $306k 46k 6.68
2025-03-31 $190k 21k 8.99
2024-12-31 $890k 52k 17.28
2024-09-30 $1.0M 66k 15.90
2024-06-30 $190k 13k 14.21
2024-03-31 $79k 5.7k 13.90